Nuveen Asset Management »

Entrada Therapeutics shares owned by Nuveen Asset Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Nuveen Asset Management from 13F filings

Historical chart of Nuveen Asset Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Nuveen Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Nuveen Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $810k 57k 14.17
2023-09-30 $1.2M 73k 15.80
2023-06-30 $860k 57k 15.14
2023-03-31 $188k 13k 14.48
2022-03-31 $130k 14k 9.37
2021-12-31 $237k 14k 17.08